Vir Shares Climb 48% on Initial Phase 1 Chronic Hepatitis B Trial Data

  ()
Vir Biotechnology shares traded higher after the company reported data from its Phase 1 Chronic Hepatitis B Study that showed VIR-3434 significantly and rapidly reduced hepatitis B surface antigen. read more >

Investors, Don't Miss Today's FREE StreetSmart Live! Broadcast!

Streetwise Reports
3 Companies You Should Be Watching… Learn About High-Grade Assets In Producing Mining Districts For Silver, Battery Metals And Platinum Elements, And Copper. read more >
News Update

Telemedicine Firm Partners to Offer Reliq Health's iUGO Care RPM and CCM Platforms

News Update
  ()
iDocsWeb reported it formed a strategic partnership with Reliq Health Technologies to offer that firm's iUGO Remote Patient Monitoring, Chronic Care Management and Behavioral Health solutions platforms to its U.S. customers. read more >

Aurinia Pharma Shares Open at 52-Week High as FDA Approves Adult Lupus Nephritis Drug

  ()
Shares of Aurinia Pharmaceuticals traded 30% higher after the company reported that the U.S. Food and Drug Administration approved its LUPKYNIS™ (voclosporin) for use in treating adults with active lupus nephritis. read more >

AzurRx Doses First Two People in Expanded Phase 2b Trial of Cystic Fibrosis Patients

  ()
AzurRx BioPharma shares traded 45% higher after the firm advised it had dosed the first two patients in its Phase 2b OPTION 2 Extension Study of MS1819 for treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis. read more >

Imagin Medical Is Bringing Cystoscopy into the 21st Century

Contributed Opinion
  ()
Dr. KSS, MD, PhD, editor-in-chief of PubBio.co, profiles a small cap that "is poised to bring to clinic a next-generation of must-have cystoscopy equipment." read more >
News Update

Healthcare Tech Firm Announces New Multilingual IVR Product

News Update
  ()
Reliq Health Technologies launched a multilingual interactive voice recognition product called iUGO Care IVR and has contracted with a Maryland physician practice to offer the service to patients speaking Russian and English. read more >

A Solace to the Stress of the SolarWinds Hack

Contributed Opinion
  ()
Against the backdrop of the massive SolarWinds hack, value investor Jack Hurley discusses his investment thesis for Leonovus Inc, whose products provide an "ironclad level of cybersecurity." read more >

Gritstone Oncology Licenses LNP Platform from Genevant Sciences to Develop COVID-19 Vaccine

  ()
Shares of Gritstone Oncology reached a new 52-week high price after the company advised it entered into a non-exclusive licensing agreement with Genevant Sciences to develop and commercialize self-amplifying RNA vaccines for use against SARS-CoV-2. read more >
News Update

Biotech Given Go-Ahead to Proceed with Phase 3 COVID-19 Study

News Update
  ()
Algernon Pharmaceuticals reported that it has been granted approval from the Data and Safety Monitoring Board to conduct a Phase 3 Study of Ifenprodil for SARS-CoV-2. read more >
News Update

Life Sciences Firm Partners with University to Develop Biosynthetic Psilocybin

News Update
  ()
Revive Therapeutics entered into a research agreement with North Carolina State University to develop psilocybin utilizing a natural biosynthesis enzymatic platform. read more >

Aclaris Shares Triple in Value on Positive Topline Data from Phase 2a Rheumatoid Arthritis Trial

  ()
Shares of Aclaris Therapeutics Inc. soared to a new 52-week high after the company reported positive preliminary topline data from its Phase 2a trial of oral ATI-450 for moderate to severe rheumatoid arthritis. read more >

Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD

  ()
Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereye™ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease. read more >

Expert Investing Ideas

"AGN [shares] are now in a vigorous uptrend."

–Clive Maund, CliveMaund.com


"SPR is the number one cannabis stock to own today."

–Cynthia Berryman, Financial News Now



The Life Sciences Report Readers, Be the First to Hear Direct from the Experts…Live and in Real Time!

Founded by the same team that brought you The Life Sciences Report.

Get Our Streetwise Reports Life Sciences Report Newsletter Free and be the first to know!

A valid email address is required to subscribe
NASDAQ Biotech ARCA Pharmaceutical
News Update

Neurosciences Firm Outlines Strategic Priorities for 2021

News Update
  ()
ProMIS Neurosciences discusses its four priority areas in 2021. read more >

Inari Shares Flow 14% Higher on Triple Digit YoY Growth in Procedures and Revenues

  ()
Shares of Inari Medical Inc. established a new 52-week high after the company reported that preliminary revenue in Q4/20 increased year-over-year by greater than 140%. read more >

As Psychedelics Move Mainstream, Small Cap Positions Itself at the Center of the Industry

  ()
Two year old DELIC Corp. has gotten in on the ground floor of the nascent psychedelic sector. read more >